MDB - MELIOIDOSIS DATABASE

  References

  1. Ashdown LR and Guard RW, The prevalence of melioidosis in Northern Queensland. Am. J. Trop. Med. Hyg, 33 (3): 474 - 8, (1984).
  2. Ashdown LR, Indirect haemagglutination test for melioidosis. Med J Aust, 147 (7): 364 - 5, (1987).
  3. Ashdown LR, In-vitro activities of the newer b-lactam and quinolone agents against Pseudomonas pseudomallei. Antimicrob. Agents Chemother, 32 (9): 1435 - 36, (1988).
  4. Barnes JL, Warner J, et al. Adaptive immunity in melioidosis: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei. Clin. Immunol, 113 (1): 22 - 8, (2004).
  5. Bharadwaj R, Kagal A, et al. Outbreak of plague- like illness caused by Pseudomonas pseudomallei in Maharashtra, India. Lancet, 344 (8936): 1574, (1994).
  6. Chantratita N, Tandhavanant S, et al. Proteomic analysis of colony morphology variants of Burkholderia pseudomallei defines a role for the arginine deiminase system in bacterial survival. J Proteomics, 75 (3): 1031 - 42, (2012).
  7. Chaowagul W, Recent advances in the treatment of severe melioidosis. Acta Trop, 74 (2-3): 133 - 7, (2000).
  8. Cheng AC and Currie BJ, Melioidosis: Epidemiology, Pathophysiology, and Management. Clin Microbiol Rev, 18 (2): 383 - 416, (2005).
  9. Cherian T, Raghupathy P, et al. Plague in India. Lancet, 345 (8944): 258 - 9, (1995).
  10. Cooper A, Williams NL, et al. ELISA and immune-polymerase chain reaction assays for the sensitive detection of melioidosis. Diagn Microbiol Infect Dis, 75 (2): 135 - 8, (2013).
  11. Currie B, Melioidosis in Papua New Guinea: is it less common than in tropical Australia? Trans. R. Soc. Trop. Med. Hyg, 87 (4): 417, (1993).
  12. Currie BJ, Fisher DA, et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop, 74 (2 - 3): 121 - 27, (2000).
  13. Currie BJ, Jacups SP, et al. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop. Med. Int. Health, 9 (11): 1167 - 74, (2004).
  14. Dance DA, Melioidosis: the tip of the iceberg? Clin Microbiol Rev, 4 (1): 52 - 60, (1991).
  15. Dance DA, Wuthiekanun V, et al. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance In-vitro and during treatment. J. Antimicrob. Chemother, 24 (3): 295 - 309, (1989).
  16. Gibney KB, Cheng AC, et al. Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis, 47 (5): 603 - 9, (2008).
  17. Harley VS, Dance DA, et al. An ultrastructural study of the phagocytosis of Burkholderia pseudomallei. Microbios, 94 (377): 35 - 45, (1998).
  18. Holden MT, Titball RW, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci, 101 (39): 14240 - 45, (2004).
  19. Howe CA, Sampath, et al. The pseudomallei group: a review. J. Infect. Dis, 124 (6): 598 - 606, (1971).
  20. Jabbar Z and Currie BJ, Melioidosis and the kidney. Nephrology (Carlton), 18 (3): 169 - 75, (2013).
  21. Jansen A, Hagen RM, et al. Pulmonary melioidosis associated with bronchiolotis obliterans organizing pneumonia. J Infect, 50 (1): 68 – 71, (2005).
  22. Jesudason MV, Anbarasu A, et al. Septicaemic melioidosis in a tertiary care hospital in south India. Indian J Med Res, 117: 119 - 21, (2003).
  23. John TJ, Jesudason MV, et al. Melioidosis in India: the tip of the iceberg? Indian J. Med.Res, 103: 62 - 5, (1996).
  24. Jones AL, Beveridge TJ, et al. Intracellular survival of Burkholderia pseudomallei. Infect. Immun, 64 (3): 782 - 90, (1996).
  25. Kespichayawattana W, Rattanachetkul S, et al. Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cell-to-cell spreading. Infect Immun, 68 (9): 5377 - 84, (2000).
  26. Leelarasamee A and Bovornkitti S, Melioidosis: review and update. Rev. Infect. Dis, 11 (3): 413 - 25, (1989).
  27. Lertmemongkolchai G, Cai G, et al. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol, 166 (2): 1097 - 105, (2001).
  28. Limmathurotsakul D and Peacock SJ, Melioidosis: a clinical overview. Br Med Bull, 99: 125 - 39, (2011).
  29. Limmathurotsakul D, Jamsen K, et al. Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One, 5 (8): e12485, (2010).
  30. Loveleena, Chaudhry R, et al. Melioidosis; the remarkable imitator: recent perspectives. J Assoc Physicians India, 52: 417 - 420, (2004).
  31. Mathai E, Jesudason MV, et al. Indirect immunofluorescent antibody test for the rapid diagnosis of melioidosis. Indian J Med Res, 118: 68 - 70, (2003).
  32. Mickail N, Klein NC, et al. Melioidosis breast abscesses. J Infect, 64 (4): 434 - 5, (2012).
  33. Naigowit P, Maneeboonyoung W, et al. Serosurveillance for Pseudomonas pseudomallei infection in Thailand. Jpn. J. Med, Sci. Biol, 45 (5-6): 215 - 230, (1992).
  34. O'Brien M, Freeman K, et al. Further evaluation of a rapid diagnostic test for melioidosis in an area of endemicity. J Clin Microbiol, 42 (5): 2239 - 40, (2004).
  35. Pruksachartvuthi S, Aswapokee N, et al. Survival of Pseudomonas pseudomallei in human phagocytes. J. Med. Microbiol, 31 (2): 109 - 14, (1990).
  36. Raghavan KR, Shenoi RP, et al. Melioidosis in India. Indian Pediatr, 28 (2): 184 - 188, (1991).
  37. Salanoubat M, Genin S, et al. Genome sequence of the plant pathogen Ralstonia solanacearum. Nature, 415 (6871): 497 - 502, (2002).
  38. Santanirand P, Harley VS, et al. Interferon-gamma mediates host resistance in a murine model of melioidosis. Biochem. Soc. Trans, 25 (2): 287S, (1997).
  39. Saravu K, Mukhopadhyay C, et al. Melioidosis in southern India: epidemiological and clinical profile. Southeast Asian J Trop Med Public Health, 41 (2): 401 - 9, (2010).
  40. Sekhri K, Antimicrobial resistance: Understanding solutions and future developments. Int. J. PharmaBiosci, 4 (2): 338 - 43, (2013).
  41. Steinmetz I, Rohde M, et al. Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. Infect. Immun, 63 (10): 3959 - 65, (1995).
  42. Suputtamongkol Y, Hall AJ, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int. J. Epidemiol, 23 (5): 1082 - 90, (1994).
  43. Teo L, Tay YK, et al. Cutaneous melioidosis. J Eur Acad Dermatol Venereol, 20 (10): 1322 - 24, (2006).
  44. Van Phung L, Quynh HT, et al. Pilot study of exposure to Pseudomonas pseudomallei in Northern Vietnam. Trans. R. Soc. Trop. Med. Hyg, 87 (4): 416, (1993).
  45. Vorachit M, Lam K, et al. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole. Antimicrob. Agents Chemother, 37 (9): 2000 - 2, (1993).
  46. Walsh AL, Smith MD, et al. Immunofluorescence microscopy for the rapid diagnosis of melioidosis. J Clin Pathol, 47 (4): 377 - 9, (1994).
  47. Warner J, Learoyd D, et al. Melioidosis in the Western Province of Papua New Guinea. In: Annual Scientific Meeting, Medical Society of Papua New Guinea, Port Moresby, pp: 38, (1998).
  48. White NJ, Melioidosis. Lancet, 361 (9370): 1715 - 22, (2003).
  49. Wuthiekanun V, Desakorn V, et al. Rapid Immunofluorescence Microscopy for Diagnosis of Melioidosis. Clin Diagn Lab Immunol, 12 (4): 555 - 6, (2005).
  50. Yabuuchi E, Kosako Y, et al. Proposal of Burkholderia gen. nov. a`nd transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol, 36 (12): 1251 - 75, (1992).